Mitoxantrone
Jump to navigation
Jump to search
Mitoxantrone is an antineoplastic agent used in medical oncology as part of combination therapy for a variety of cancers. It is also used in severe relapsing-remitting multiple sclerosis.
The drug is of the anthracycline class, specifically an anthracenedione.
Indications
Approved in humans
Acute myeloid and Acute promyelocytic leukemia, Advanced hormone refractory prostate cancer pain, erythroid leukemia, Relapsing and remitting multiple sclerosis
Off-label human uses
Follicular B-Cell Non-Hodgkin's lymphoma, Metastatic breast carcinoma, progressive diffuse large B-Cell lymphoma